中国临床药学杂志

参考文献

[1]张松,祁冬冬,倪静,等.Stevens-Johnson综合征及中毒性表皮坏死松解症48例临床资料分析[J].临床皮肤科杂志,2019,48(11):665.

[2]胡丽,黄琨,俞仁涛.Stevens-Johnson综合征和中毒性表皮坏死松解症的疾病进展和治疗转归分析[J].中国皮肤性病学杂志,2022,36(3):290.

[3]NG C Y,CHEN C B,WU M Y,et al.Anticancer drugs induced severe adverse cutaneous drug reactions:an updated review on the risks associated with anticancer targeted therapy orimmunotherapies[J].J Immunol Res,2018,2018:5376476.

[4]REIGNER B,BLESCH K,WEIDEKAMM E.Clinical pharmacokinetics of capecitabine[J].Clin Pharmacokinet,2001,40(2):85.

[5]毛书青.结直肠癌患者应用奥沙利铂联合卡培他滨辅助化疗的不良反应及护理体会[J].家有孕宝,2021,3(9):145.

[6]NARANJO C A,BUSTO U,SELLERS E M,et al.A method for estimating the probability of adverse drug reactions[J].Clin Pharmacol Ther,1981,30(2):239.

[7]AHN H R,LEE S K,YOUN H J,et al.Stevens-Johnson syndrome and concurrent hand foot syndrome during treatment with capecitabine:a case report[J].World J Clin Cases,2021,9(17):4279.

[8]JADHAV P,ROGERS J E,SHROFF R.A case report—StevensJohnson syndrome as an adverse effect of capecitabine[J].J Gastrointest Cane,2018,49(3):349.

[9]KARTHIKEYAN K,SAMEERA K V,SHAJI S,et al.Capecitabine induced Steven-Johnson syndrome:a rare case report[J].J Oncol Pharm Pract,2022.28(1):250.

[10]MITTMANN N,KNOWLES S R,KOO M,et al.Incidence of toxic epidermal necrolysis and Stevens-Johnson syndrome in an HIV cohort[J].Am J Clin Dermatol,2012,13(1):49.

[11]中华医学会皮肤性病学分会药物不良反应研究中心.StevensJohnson综合征/中毒性表皮坏死松解症诊疗专家共识[J].中华皮肤科杂志,2021,54(5):376.

[12]佘秋云,董盈盈,邓云华.《2016英国成人Stevens-Johnson综合征/中毒性表皮坏死松解症管理指南》解读[J].中国医学文摘(皮肤科学),2017,34(3):273.

[13]杨月,赵莉,王伟东.1例氟康唑致中毒性表皮坏死松解症患者的药学监护[J].中国现代应用药学,2020,37(16):2002.

[14]江益娟.1例重症药疹患者的药学监护[J].中国药师,2014,17(5):850.

[15]梁源,张立新,李楠,等.儿童中毒性表皮坏死松解症15例临床分析[J].中国皮肤性病学杂志,2015,29(5):472.

[16]SCHWARTZ R A,MCDONOUGH P H,LEE B W.Toxic epidermal necrolysis:part I.Introduction,history,classification,clinical features,systemic manifestations,etiology,and immunopathogenesis[J].J Am Acad Dermahtol,2013,69(2):173.

[17]SCHNECK J.FAGOT J P,SEKULA P,et al.Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis:a retrospective study on patients included in the prospective EuroSCAR Study[J].J Am Acad Dermatol,2008,58(1):33.

[18]KARDAUN S H,JONKMAN M F.Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis[J].Acta Derm Venereol,2007,87(2):144.

[19]HIRAHARA K,KANO Y,SATO Y,et al.Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis:clinical evaluation and analysis of biomarkers[J].J Am Acad Dermatol,2013,69(3):496.

[20]US Department of Health and Human Services,National Institutes of Health,National Cancer Institute.Common terminology criteria for adverse events(CTCAE)[M].Version 5.NIH Publication,2010:0-71.

[21]黄莉,李甜.Stevens-Johnson综合征/中毒性表皮坏死松解症[J].中国小儿急救医学,2019,26(5):326.

[22]杨永生,徐金华,李锋,等.静脉注射丙种球蛋白和糖皮质激素治疗重症大疱性药疹65例[J].中华皮肤科杂志,2009,42(5):330.

[23]陈金波,王宝玺,王宏伟,等.Stevens-Johnson综合征及中毒性表皮坏死松解症61例回顾性分析[J].中华皮肤科杂志,2008,41(8):542.